Histiocytic Disorders and Treatments
Histiocytic Disorders and Treatments is a research topic within Physiology. Science Explorer counts 12k research works in it since 1950. 10.3% of them reached the world's top 10% most cited for their field and year.
This cluster of papers focuses on the classification, diagnosis, and treatment of histiocytic disorders, including Langerhans Cell Histiocytosis and Erdheim-Chester Disease. It explores the role of BRAF mutations, immunohistochemical approaches to classification, and consensus guidelines for clinical management. The papers also delve into the pathogenesis, molecular characterization, and therapy intensification for multisystem involvement.
- Langerhans Cell Histiocytosis
- Erdheim-Chester Disease
- Dendritic Cell Neoplasms
- BRAF Mutations
- Clinical Management
- Immunohistochemical Approach
- Multisystem Involvement
- Therapy Intensification
- Pathogenesis
- Molecular Characterization
- Research works
- 12k fractional, since 1950
- In the world top 10%
- 1.2k per year above
- Top-10% rate
- 10.3% share of its works in the world top 10%
- Growth, 2018-21 → 2022-25
- +8% the tick is no change
- Largest producer
United States
32% of the 10 largest, 2022-now
This ranks research output and citation impact. It says nothing about the quality of diagnosis, treatment or care.
Which countries lead Histiocytic Disorders and Treatments research?
By volume, the United States and China publish the most (508 and 332 works in 2022-now).
Japan
Brazil
Spain
Italy
Türkiye
GermanyHow concentrated that is
The same countries as shares of everything the list above accounts for. A node where two countries do two thirds of the work and one spread evenly across twelve read alike as a ranking and not at all alike here.
Shares of the rows listed above, not of the whole node.
Which institutions lead Histiocytic Disorders and Treatments research?
By volume in 2022-now, Mayo Clinic publishes the most Histiocytic Disorders and Treatments research, followed by All India Institute of Medical Sciences and Sichuan University.
By volume, 2022-now
- 1
Mayo ClinicUnited States
28 works
- 2
All India Institute of Medical Sciences
India
27 works
- 3
Sichuan University
China
21 works
- 4
Harvard UniversityUnited States
20 works
- 5
Capital Medical UniversityChina
19 works
- 6
Chinese Academy of Medical Sciences & Peking Union Medical CollegeChina
17 works
- 7
Tsinghua UniversityChina
15 works
- 8
Assistance Publique – Hôpitaux de Paris
France
12 works
- 9
Sorbonne UniversitéFrance
12 works
- 10
Université Paris CitéFrance
11 works
Who are the leading researchers in Histiocytic Disorders and Treatments?
The most-cited researchers publishing on Histiocytic Disorders and Treatments include Jun Wang, Gregory Y.H. Lip and Hagop M. Kantarjian.
- 1
Jun Wang
China
340k citations
- 2
Gregory Y.H. Lip
United Kingdom
311k citations
- 3
Hagop M. Kantarjian
United States
273k citations
- 4
Kaj Blennow
Sweden
247k citations
- 5
Richard Anthony Flavell
United States
237k citations
Ranked by citations received across their whole record, among researchers with at least three works on this topic.
Where is Histiocytic Disorders and Treatments research done?
The largest centres of Histiocytic Disorders and Treatments research in 2022-now are Beijing (China), Paris (France), New Delhi (India) and Chengdu (China).
Where is the best place to study Histiocytic Disorders and Treatments?
Among universities, judged by research, Harvard University, Sorbonne Université and Capital Medical University score highest, combining citation excellence, specialisation, size, growth and international reach. Research strength is one signal when choosing where to study; it does not measure teaching.
One dot per university in the first ten of the table below, at the default weights. The upper left is the interesting corner: small places doing unusually strong work.
| # | University | Score | Top 10% | Specialisation | Works | Growth |
|---|---|---|---|---|---|---|
| 1 | Harvard UniversityUnited States |
75.5 | 22.9% | 3.4× | 20 | -11.1% |
| 2 | Sorbonne UniversitéFrance |
62.8 | 15.5% | 9.6× | 12 | -0.6% |
| 3 | Capital Medical UniversityChina |
59.1 | 14.3% | 9.8× | 20 | +75.6% |
| 4 | Sichuan UniversityChina |
55.5 | 11.6% | 4.9× | 21 | +41.6% |
| 5 | Chinese Academy of Medical Sciences & Peking Union Medical CollegeChina |
55.4 | 12.1% | 8.4× | 17 | +39.2% |
| 6 | Université Paris CitéFrance |
54.8 | 22.8% | 7.6× | 11 | -15.3% |
| 7 | University of Alabama at BirminghamUnited States |
53.8 | 21.9% | 10.2× | 9 | +192.7% |
| 8 | All India Institute of Medical SciencesIndia |
50.0 | 0.9% | 13.2× | 27 | +25.9% |
| 9 | Tsinghua UniversityChina |
48.7 | 12.3% | 3.5× | 15 | +55.4% |
| 10 | Baylor College of MedicineUnited States |
45.7 | 14.3% | 10.8× | 10 | -2.2% |
| 11 | Shanghai Jiao Tong UniversityChina |
33.4 | 13.6% | 1.7× | 9 | +15.2% |
| 12 | Peking UniversityChina |
29.7 | 7.0% | 2.6× | 10 | +45.8% |
| 13 | Zhejiang UniversityChina |
28.9 | 9.1% | 2.0× | 10 | +54.1% |
| 14 | Post Graduate Institute of Medical Education and ResearchIndia |
13.3 | 3.5% | 14.5× | 9 | -24.6% |
Universities only. The score blends citation excellence (40%), size (30%), specialisation (10%), growth (10%), international reach (10%), 2022-now; growth compares 2018-21 with 2022-25 and counts up to +20%, since a jump from a small base is mostly noise.
Every institution in Histiocytic Disorders and Treatments, country by countryIs Histiocytic Disorders and Treatments research growing?
Output in 2022-2025 was 8% higher than in 2018-2021, peaking in 2025. The fastest-growing topics are Histiocytic Disorders and Treatments.
The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.
Its share of all research
Growing output can still be a shrinking share: all of science grows. This is Histiocytic Disorders and Treatments as a percentage of every work published that year, 0.0087% in 2024.
Fractional works of Histiocytic Disorders and Treatments over all fractional works that year. How the balance of science has shifted.
How much of it reaches the world top 10%
Year by year.
Of each year's works in it, the share that reached the world's 10% most cited for their field and year. A field is the world for its own topics, so there is no other line to hold it against.
Which topics inside it are moving
Growth and decline on one axis around a shared zero. Two lists side by side hide the thing that matters: whether the growth dwarfs the decline, or the other way round.
Discussion
Ask a question or share a note about Histiocytic Disorders and Treatments. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.